Citation: V. Broadbent et H. Gadner, CURRENT THERAPY FOR LANGERHANS CELL HISTIOCYTOSIS, Hematology/oncology clinics of North America, 12(2), 1998, pp. 327
Citation: V. Broadbent, DIABETES-INSIPIDUS ASSOCIATED WITH LANGERHANS CELL HISTIOCYTOSIS - ISIT REVERSIBLE - REPLY, Medical and pediatric oncology, 30(3), 1998, pp. 198-198
Citation: V. Broadbent et J. Pritchard, DIABETES-INSIPIDUS ASSOCIATED WITH LANGERHANS CELL HISTIOCYTOSIS - ISIT REVERSIBLE, Medical and pediatric oncology, 28(4), 1997, pp. 289-293
Authors:
JONES N
WILLIAMS D
BROADBENT V
JESTICE K
BORAKS P
SCOTT M
AGER S
MARCUS R
Citation: N. Jones et al., HIGH-DOSE MELPHALAN FOLLOWED BY AUTOGRAFT EMPLOYING NONCRYOPRESERVED PERIPHERAL-BLOOD PROGENITOR CELLS IN CHILDREN, European journal of cancer, 32A(11), 1996, pp. 1938-1942
Citation: S. Ager et al., AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR 2ND OR GREATER COMPLETE REMISSION OF ACUTE MYELOID-LEUKEMIA AND ACUTE LYMPHOBLASTIC-LEUKEMIA, Leukemia & lymphoma, 18(3-4), 1995, pp. 349-351
Authors:
CHESSELLS JM
BAILEY C
RICHARDS SM
EDEN OB
BARBOR PRH
BARRETT A
BARTON C
BROADBENT V
DEMPSEY SI
DURRANT J
EMERSON P
EVANS DIK
FENNELLY JJ
GALTON DAG
GIBSON B
GRAY R
HANN IM
HARDISTY RM
HILL FGH
KERNAHAN J
KING DJ
LILLEYMAN JS
MANN J
MARTIN J
MCELWAIN TJ
MELLOR ST
JONES PHM
OAKHILL A
PETO J
RADFORD M
REES JKH
STEVENS RF
SUMMERFIELD GP
THOMPSON EN
Citation: Jm. Chessells et al., INTENSIFICATION OF TREATMENT AND SURVIVAL IN ALL CHILDREN WITH LYMPHOBLASTIC-LEUKEMIA - RESULTS OF UK MEDICAL-RESEARCH-COUNCIL TRIAL UKALL-X, Lancet, 345(8943), 1995, pp. 143-148
Authors:
LADISCH S
GADNER H
ARICO M
BROADBENT V
GROIS N
JACOBSON A
KOMP D
NICHOLSON HS
Citation: S. Ladisch et al., LCH-I - A RANDOMIZED TRIAL OF ETOPOSIDE VS VINBLASTINE IN DISSEMINATED LANGERHANS CELL HISTIOCYTOSIS, Medical and pediatric oncology, 23(2), 1994, pp. 107-110
Citation: Rm. Irving et al., LANGERHANS CELL HISTIOCYTOSIS IN CHILDHOOD - MANAGEMENT OF HEAD AND NECK MANIFESTATIONS, The Laryngoscope, 104(1), 1994, pp. 64-70
Citation: V. Broadbent et al., LANGERHANS CELL HISTIOCYTOSIS - CLINICAL AND EPIDEMIOLOGIC ASPECTS, British Journal of Cancer, 70, 1994, pp. 190000011-190000016
Citation: L. Brandt et V. Broadbent, A SURVEY OF RECOMMENDATIONS GIVEN TO PATIENTS GOING HOME AFTER BONE-MARROW TRANSPLANT, Archives of Disease in Childhood, 71(6), 1994, pp. 529-531
Citation: S. Ager et al., SURVIVAL OUTCOME IN PATIENTS TREATED IN 2ND OR MORE COMPLETE REMISSION WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION - A COMPARISON BETWEEN ALL AND AML, Experimental hematology, 21(8), 1993, pp. 1063-1063
Authors:
BROADBENT V
DUNGER DB
YEOMANS E
KENDALL B
Citation: V. Broadbent et al., ANTERIOR-PITUITARY FUNCTION AND COMPUTED-TOMOGRAPHY MAGNETIC-RESONANCE-IMAGING IN PATIENTS WITH LANGERHANS CELL HISTIOCYTOSIS AND DIABETES-INSIPIDUS, Medical and pediatric oncology, 21(9), 1993, pp. 649-654